DTIC ADA482909: Development of Antigen Presenting Cells pdf

DTIC ADA482909: Development of Antigen Presenting Cells

More Book Details

Description of the Book:

While adoptive immunotherapy holds promise as a treatment for cancer and infectious diseases, development has been impeded by the lack of reproducible methods for generating therapeutic numbers of antigen-specific CD8+ CTL. As a result, there are only limited reports of expansion of antigen-specific CTL to levels required for clinical therapy. Therefore, our groups has previously developed artificial Antigen-Presenting Cells (aAPC), made by coupling soluble HLAIg and anti-CD28 to beads. These aAPC have successfully been used to induce and expand CTL specific for CMV or melanoma. For the current study we have proposed to used and further developed those aAPC for the generation of prostate cancer specific CTL. Our preliminary data demonstrate that aAPC loaded with the prostate cancer specific antigen EpHA2 have been used to generate functional active prostate cancer-specific CTL from peripheral blood healthy donors

• Creator/s: Defense Technical Information Center
• Date: 12/1/2007
• Year: 2007
• Book Topics/Themes: DTIC Archive, Oelke, Mathias, JOHNS HOPKINS UNIV BALTIMORE MD, *PROSTATE CANCER, *ANTIGENS, *IMMUNOTHERAPY, INFECTIOUS DISEASES, CELLS(BIOLOGY), DENDRITIC STRUCTURE, BLOOD, THERAPY, NEOPLASMS, CLINICAL MEDICINE, REPRODUCIBILITY

An excerpt captured from the PDF book